Bionano Genomics, Inc. — Director's Dealing 2019

Jan 22, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioNano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2019-01-18

Reporting Person: Borodkin Mark (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-18	Common Stock	M	6000	$1.30	Acquired	6815	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-18	Stock Option (Right to Buy)	$1.30	M	6000	Disposed	2027-02-06	Common Stock (6000)	Direct

Footnotes

F1: 25% of the shares vested on February 7, 2017, and the remaining shares vest in 12 equal quarterly installments thereafter.